Listed

Cognizant Technology Solutions Corp: Form 10-Q for the period ended Jun 30, 2024

Filed with the SEC on Aug 1, 2024 and accepted by EDGAR at Jul 31, 2024, 17:36 ET.

Share

Management's discussion and analysis

As filed, 49,598 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Executive Summary

Cognizant is one of the world’s leading professional services companies, engineering modern businesses and delivering strategic outcomes for our clients. We help clients modernize technology, reimagine processes and transform experiences so they can stay ahead in a fast-changing world. We provide industry expertise and close client collaboration, combining critical perspective with a flexible engagement style. We tailor our services and solutions to specific industries with an integrated global delivery model that employs client service and delivery teams based at client locations and dedicated global and regional delivery centers. Our collaborative services include digital services and solutions, consulting, application development, systems integration, quality engineering and assurance, application maintenance, infrastructure and security as well as business process services and automation. Digital services continue to be an important part of our portfolio, aligning with our clients' focus on becoming data-enabled, customer-centric and differentiated businesses.

In the second quarter of 2023, we initiated the NextGen program aimed at simplifying our operating model, optimizing corporate functions and consolidating and realigning office space to reflect the post-pandemic hybrid work environment. Our drive for simplification includes operating with fewer layers in an effort to enhance agility and enable faster decision making. We expect the savings generated by the program to help fund continued investments in our people, revenue growth opportunities and the modernization of our office space.

In connection with the NextGen program, in the second quarter of 2024 we incurred $29 million of employee separation, facility exit and other costs. Since the inception of the program, we incurred $281 million in total costs. See Note 4 to our unaudited consolidated financial statements. We currently expect to incur costs of approximately $95 million for the full year 2024, which is expected to bring the total charges under the program to approximately $325 million. The estimates of the charges and expenditures that we expect to incur in connection with the NextGen program, and the timing thereof, are subject to a number of assumptions, including local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, we may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur in connection with the NextGen program.

Q2 2024 Financial Results1

Revenue

Income from Operations

Operating Margin

Diluted EPS

GAAP Adjusted1

GAAP Adjusted1

GAAP Adjusted1

Revenue down $36 million or 0.7% from Q2 2023; a decline of 0.5% in constant currency1 Income from Operations up $131 million or 22.7% from Q2 2023 Adjusted Income from Operations1 up $43 million or 6.2% from Q2 2023 Operating margin up 280 bps from Q2 2023 Adjusted Operating Margin1 up 100 bps from Q2 2023 Diluted EPS up $0.23 or 25.3% from Q2 2023 Adjusted Diluted EPS1 up $0.07 or 6.4% from Q2 2023

During the quarter ended June 30, 2024, revenues decreased by $36 million as compared to the quarter ended June 30, 2023, representing a decrease of 0.7%, or a decrease of 0.5% on a constant currency1 basis. Revenues were negatively impacted by weakness in our Products and Resources and Financial Services segments, partially offset by revenue growth in our Health Sciences and Communications, Media and Technology segments.

1 Adjusted Income from Operations, Adjusted Operating Margin, Adjusted Diluted EPS and constant currency revenue growth are not measures of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures, as applicable.

Our operating margin increased to 14.6% and Adjusted Operating Margin2 increased to 15.2% for the quarter ended June 30, 2024, from operating margin of 11.8% and Adjusted Operating Margin of 14.2% for the quarter ended June 30, 2023. The increase in our GAAP and Adjusted Operating Margins for the quarter ended June 30, 2024 as compared to the quarter ended June 30, 2023 was primarily driven by net savings generated from our NextGen program and the beneficial impact of foreign currency exchange rate movements, partially offset by the insurance recovery benefit of 60 basis points during the second quarter of 2023 related to a previously disclosed 2020 cyber incident and the impact of the resale of third-party products in connection with our integrated offerings strategy. In addition, our GAAP operating margins for the quarters ended June 30, 2024 and 2023, were negatively impacted by the NextGen charges, as discussed in Note 4 to our unaudited consolidated financial statements, which were excluded from our Adjusted Operating Margin.

As a global professional services company, we compete on the basis of the knowledge, experience, insights, skills and talent of our employees and the value they can provide to our clients. We closely monitor attrition trends focusing on the metric that we believe is most relevant to our business. This metric, which we refer to as Voluntary Attrition - Tech Services, includes all voluntary separations with the exception of employees in our Intuitive Operations and Automation practice. For the trailing twelve months ended June 30, 2024 our Voluntary Attrition - Tech Services was 13.6% as compared to 19.9% for the trailing twelve months ended June 30, 2023. We finished the second quarter of 2024 with approximately 336,300 employees as compared to 345,600 employees at the end of the second quarter of 2023.

Business Outlook

We continue to expect the long-term focus of our clients to be on their digital transformation into AI-ready, software-driven, data-enabled, customer-centric and differentiated businesses. We believe clients will continue to contend with industry-specific changes driven by evolving digital technologies, uncertainty in the regulatory environment, industry consolidation and convergence as well as international trade policies and other macroeconomic and geopolitical factors, including the uncertainty related to the global economy, which has affected and may continue to affect their demand for our services.

We increasingly use AI-based technologies, including GenAI, in our client offerings and our own internal operations. AI technologies and services are part of a highly competitive and rapidly evolving market. We plan to make significant investments in our AI capabilities to meet the needs of our clients and harness its value in a flexible, secure, scalable and responsible way. As AI-based technologies evolve, we expect that some services that we currently perform for our clients will be replaced by AI or other forms of automation. This may lead to reduced demand for certain services or harm our ability to obtain favorable pricing or other terms for our services.

We currently expect to incur total costs of approximately $325 million in connection with the NextGen program, which started in the second quarter of 2023, with approximately $95 million of such costs anticipated in 2024. See "Executive Summary." In addition to the NextGen program, potential tax law and other regulatory changes, including possible U.S. corporate income tax reform and the Code on Social Security, 2020 in India, among other items, may impact our future results. We expect that the Code on Social Security, 2020, if enacted as currently written, could result in a material one-time increase to our post-employment liability for past service and would also modestly increase our costs for employment and post-employment benefits prospectively. In addition, in March 2024, India and Mauritius signed a Protocol to amend the India-Mauritius Income Tax Treaty. We are currently evaluating the potential impact of the amendment, which, depending on its final terms when entered into force, could increase our effective income tax rate, as CTS India is a subsidiary of our wholly-owned Mauritius entity.

On June 10, 2024, we announced the signing of a definitive agreement to acquire Belcan, a portfolio company of AE Industrial Partners and a leading global supplier of engineering research & development services, for a preliminary purchase price of approximately $1.3 billion in cash and stock. The transaction is anticipated to close in the quarter ending September 30, 2024, subject to the receipt of required regulatory approvals and other closing conditions. This acquisition is expected to significantly expand our engineering research & development and Internet of Things capabilities. Belcan’s customers are primarily in the aerospace and defense, space and marine sectors. We expect to include these customers in our Products and Resources segment. The acquisition is expected to result in modest near-term margin dilution primarily due to transaction and integration related expenses and amortization of acquired intangibles.

2 Adjusted Operating Margin is not a measure of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures, as applicable.

Results of Operations

Three Months Ended June 30, 2024 Compared to Three Months Ended June 30, 2023

The following table sets forth, for the periods indicated, certain financial data for the three months ended June 30:

(Dollars in millions, except per share data)

2024 % of Revenues 2023 % of Revenues Increase / Decrease $%
Revenues $4,850 100.0 $4,886 100.0 $(36) (0.7)
Cost of revenues(a) 3,204 66.1 3,231 66.1 (27) (0.8)
Selling, general and administrative expenses(a) 781 16.1 830 17.0 (49) (5.9)
Restructuring charges 29 0.6 117 2.4 (88) (75.2)
Depreciation and amortization expense 128 2.6 131 2.7 (3) (2.3)
Income from operations 708 14.6 577 11.8 131 22.7
Other income (expense), net 20 10 10 100.0
Income before provision for income taxes 728 15.0 587 12.0 141 24.0
Provision for income taxes (165) (124) (41) 33.1
Income (loss) from equity method investments 3 — 3 N/A
Net income $566 11.7 $463 9.5 $103 22.2
Diluted EPS $1.14 $0.91 $0.23 25.3
Other Financial Information3
Adjusted Income from Operations and Adjusted Operating Margin $737 15.2 $694 14.2 $43 6.2
Adjusted Diluted EPS $1.17 $1.10 $0.07 6.4

(a) Exclusive of depreciation and amortization expense.

N/A Not applicable

Revenues

During the quarter ended June 30, 2024, revenues decreased by $36 million as compared to the quarter ended June 30, 2023, representing a decrease of 0.7%, or a decrease of 0.5% on a constant currency basis3. Our recently completed acquisitions contributed 60 basis points to the change in revenue.

3Adjusted Income from Operations, Adjusted Operating Margin, Adjusted Diluted EPS and constant currency revenue growth are not measures of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures, as applicable.

Revenues - Reportable Business Segments and Geographic Markets

Revenues of $4,850 million across our business segments and geographies were as follows for the three months ended June 30, 2024:

(Dollars in millions)

Q2 2024 as compared to Q2 2023 Increase / (Decrease) $% CC %4
Financial Services $(16) (1.1) (0.8)
Health Sciences 21 1.5 1.7
Products and Resources (51) (4.3) (4.1)
CMT 10 1.2 1.4
Total revenues $(36) (0.7) (0.5)

(Dollars in millions)

Q2 2024 as compared to Q2 2023 Increase / (Decrease) $% CC %4
North America $31 0.9 0.9
United Kingdom (29) (6.1) (6.5)
Continental Europe (24) (4.9) (4.0)
Europe - Total (53) (5.5) (5.2)
Rest of World (14) (4.2) (2.0)
Total revenues $(36) (0.7) (0.5)

Change in revenues was driven by the following factors:4

  • Reduced demand for discretionary work negatively impacted revenues across all segments. Clients in our Products and Resources and our Financial Services segments were particularly affected;
  • Recently completed acquisitions contributed 60 basis points of growth to the overall change in revenues, including 140 basis points of growth to our Communications, Media and Technology segment (primarily in North America) and 70 basis points of growth to our Products and Resources segment (primarily in North America);
  • The resale of third-party products primarily in the Financial Services and Health Sciences segments in North America, in connection with our integrated offerings strategy, contributed 100 basis points of growth to the overall change in revenue;
  • North America revenues in the Health Sciences and Communications, Media and Technology segments were positively impacted by the ramp up of several recently won large deals; and
  • Revenue declines in our Europe and Rest of World regions were primarily driven by weakness in the Financial Services and Products and Resources segments.

4 Constant currency revenue growth is not a measure of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures, as applicable.

Cost of Revenues (Exclusive of Depreciation and Amortization Expense)

ê $27M
— flat as a % of revenues
¡ % of Revenues

Our cost of revenues consists primarily of salaries, incentive-based compensation, stock-based compensation expense, employee benefits, project-related immigration and travel for technical personnel, subcontracting and costs of third-party products and services relating to revenues. Cost of revenues, as a percentage of revenues, was positively impacted by foreign currency exchange rate movements, offset by the resale of third-party products in connection with our integrated offerings strategy.

SG&A Expenses (Exclusive of Depreciation and Amortization Expense)

SG&A expenses consist primarily of salaries, incentive-based compensation, stock-based compensation expense, employee benefits, immigration, travel, marketing, communications, management, finance, administrative and occupancy costs. The decrease, as a percentage of revenues, was primarily driven by net savings generated from our NextGen program, partially offset by the Q2 2023 insurance recovery benefit of 60 basis points related to a previously disclosed 2020 cyber incident.

ê $49M
ê 0.9% as a % of revenues
¡ % of Revenues

Restructuring Charges

Restructuring charges consist of costs related to the NextGen program. Restructuring charges were $29 million, or 0.6% as a percentage of revenue, for the three months ended June 30, 2024, as compared to $117 million, or 2.4% as a percentage of revenue, for the three months ended June 30, 2023. For further detail on our restructuring charges see Note 4 to our unaudited consolidated financial statements.

Depreciation and Amortization Expense

Depreciation and amortization expense decreased by 2.3% and decreased by 0.1% as a percentage of revenues, during the second quarter of 2024 as compared to the second quarter of 2023.

Operating Margin and Adjusted Operating Margin5 - Overall

The increase in our GAAP operating margin and Adjusted Operating Margin5 for the quarter ended June 30, 2024 as compared to the quarter ended June 30, 2023 was primarily driven by net savings generated from our NextGen program and the beneficial impact of foreign exchange rate movements, partially offset by the insurance recovery benefit of 60 basis points in the second quarter of 2023 related to a previously disclosed 2020 cyber incident and the impact of the resale of third-party products in connection with our integrated offerings strategy. In addition, our GAAP operating margins for the quarters ended June 30, 2024 and 2023, were negatively impacted by the NextGen charges, as discussed in Note 4 to our unaudited consolidated financial statements, which were excluded from our Adjusted Operating Margin.

5 Adjusted Income from Operations and Adjusted Operating Margin are not measures of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures, as applicable.

A predominant portion of our costs in India are denominated in the Indian rupee, representing approximately 24% of our global operating costs during the three months ended June 30, 2024. These costs are subject to foreign currency exchange rate fluctuations, which have an impact on our results of operations. We enter into foreign exchange derivative contracts to hedge certain Indian rupee denominated payments in India. These hedges are intended to mitigate the volatility of the changes in the exchange rate between the U.S. dollar and the Indian rupee. Net of the impact of the hedges, the depreciation of the Indian rupee positively impacted our operating margin for the three months ended June 30, 2024 by 47 basis points as compared to the three months ended June 30, 2023.

Excluding the impact of applicable designated cash flow hedges, the depreciation of the Indian rupee against the U.S. dollar positively impacted our operating margin by 29 basis points during the three months ended June 30, 2024. Each additional 1.0% change in exchange rate between the Indian rupee and the U.S. dollar will have the effect of moving our operating margin by 19 basis points (excluding the impact of the hedges). The settlement of our cash flow hedges had a positive impact of 8 basis points on our operating margin during the three months ended June 30, 2024, compared to a negative impact of 10 basis points during the three months ended June 30, 2023.

Segment Operating Profit

Segment operating profit and operating margin percentage were as follows:

Segment operating profit% Segment operating margin

In the second quarter of 2024, segment operating margins across all our segments were positively impacted by savings generated from our NextGen program and the beneficial impact of foreign currency exchange rate movements. Segment operating profit in the Health Sciences segment was negatively impacted by resales of third-party products in connection with our integrated offerings strategy and by higher costs typical to the initial phases of several recently won large deals in this segment.

Total segment operating profit and operating margin were as follows for the three months ended June 30:

(Dollars in millions)

2024 % of Revenues 2023 % of Revenues Increase/(Decrease)
Total segment operating profit $988 20.4 $1,012 20.7 $(24)
Less: unallocated costs 280 5.8 435 8.9 (155)
Income from operations $708 14.6 $577 11.8 $131

Unallocated costs decreased for the three months ended June 30, 2024 as compared to the three months ended June 30, 2023, primarily driven by lower NextGen charges of $29 million for the three months ended June 30, 2024 as compared to $117 million for the three months ended June 30, 2023 (see Note 4 to our unaudited consolidated financial statements) as well as lower corporate expenses.

Other Income (Expense), Net

The following table sets forth total other income (expense), net for the three months ended June 30:

(in millions)

2024 2023 Increase/ Decrease
Foreign currency exchange gains $4 $5 $(1)
(Losses) on foreign exchange forward contracts not designated as hedging instruments (3) (14) 11
Foreign currency exchange gains (losses), net 1 (9) 10
Interest income 30 30 —
Interest expense (10) (10) —
Other, net (1) (1) —
Total other income (expense), net $20 $10 $10

The losses on foreign exchange forward contracts not designated as hedging instruments related to the realized and unrealized gains and losses on contracts entered into to offset our foreign currency exposures. As of June 30, 2024, the notional value of our undesignated hedges was $930 million. Interest income for the three months ended June 30, 2024 remained flat as compared to the same period in 2023. While our invested balances during the three months ended June 30, 2024 were lower as compared to the three months ended June 30, 2023 due to the required payment related to the ITD dispute in January 2024 (see Note 8 to our unaudited consolidated financial statements), we benefited from higher interest rates compared to the three months ended June 30, 2023.

Provision for Income Taxes

é $41M
¡ Effective Income Tax Rate é 1.6%

The effective income tax rate in both periods reflects the benefits of discrete items related to U.S. state income taxes.

Net Income

The increase in net income was primarily driven by an increase in income from operations, partially offset by a higher effective tax rate.

é $103M
¡ é 2.2% of Revenues

Non-GAAP Financial Measures

Portions of our disclosure include non-GAAP financial measures. These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures should be read in conjunction with our financial statements prepared in accordance with GAAP. The reconciliations of non-GAAP financial measures to the corresponding GAAP measures set forth below should be carefully evaluated.

Our non-GAAP financial measures Adjusted Operating Margin and Adjusted Income from Operations excludes unusual items, such as NextGen charges. Our non-GAAP financial measure Adjusted Diluted EPS excludes unusual items, such as NextGen charges, and net non-operating foreign currency exchange gains or losses and the tax impact of all the applicable adjustments. For further detail on the NextGen charges, see Note 4 to our unaudited consolidated financial statements. The income tax impact of each item excluded from Adjusted Diluted EPS is calculated by applying the statutory rate and local tax regulations in the jurisdiction in which the item was incurred. Constant currency revenue growth is defined as revenues for a given period restated at the comparative period’s foreign currency exchange rates measured against the comparative period's reported revenues.

We believe providing investors with an operating view consistent with how we manage the Company provides enhanced transparency into our operating results. For internal management reporting and budgeting purposes, we use various GAAP and non-GAAP financial measures for financial and operational decision-making, to evaluate period-to-period comparisons, to determine portions of the compensation for executive officers and for making comparisons of our operating results to those of our competitors. We believe that the presentation of non-GAAP financial measures, which exclude certain costs, read in conjunction with our reported GAAP results and reconciliations to the most comparable GAAP measure, as applicable, can provide useful supplemental information to our management and investors regarding financial and business trends relating to our financial condition and results of operations.

A limitation of using non-GAAP financial measures versus financial measures calculated in accordance with GAAP is that non-GAAP financial measures may exclude costs that are recurring such as net non-operating foreign currency exchange gains or losses. In addition, other companies may calculate non-GAAP financial measures differently than us, thereby limiting the usefulness of these non-GAAP financial measures as a comparative tool. We compensate for these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP financial measures to allow investors to evaluate such non-GAAP financial measures.

The following table presents a reconciliation of each non-GAAP financial measure to the most comparable GAAP measure for the three months ended June 30:

2024 % of Revenues 2023 % of Revenues
GAAP income from operations and operating margin $708 14.6 $577 11.8
NextGen charges(1) 29 0.6 117 2.4
Adjusted Income from Operations and Adjusted Operating Margin $737 15.2 $694 14.2
GAAP diluted EPS $1.14 $0.91
Effect of NextGen charges, pre-tax 0.06 0.23
Non-operating foreign currency exchange (gains) losses, pre-tax (2) — 0.02
Tax effect of above adjustments(3) (0.03) (0.06)
Adjusted Diluted EPS $1.17 $1.10

(1) Consists of employee separation, facility exit and other costs incurred in connection with the NextGen program. See Note 4 to our unaudited consolidated financial statements for additional information.

(2) Non-operating foreign currency exchange gains and losses, inclusive of gains and losses on related foreign exchange forward contracts not designated as hedging instruments for accounting purposes, are reported in "Foreign currency exchange gains (losses), net" in our unaudited consolidated statements of operations.

(3) Presented below are the tax impacts of our non-GAAP adjustments to pre-tax income:

(in millions)

Non-GAAP income tax benefit (expense) related to: Three Months Ended June 30, 2024 2023
NextGen charges $8 $31
Foreign currency exchange gains and losses 1 —

The effective tax rate related to non-operating foreign currency exchange gains and losses varies depending on the jurisdictions in which such income and expenses are generated and the statutory rates applicable in those jurisdictions. As such, the income tax effect of non-operating foreign currency exchange gains and losses shown in the above table may not appear proportionate to the net pre-tax foreign currency exchange gains and losses reported in our unaudited consolidated statements of operations.

Six Months Ended June 30, 2024 Compared to Six Months Ended June 30, 2023

The following table sets forth, for the periods indicated, certain financial data for the six months ended June 30:

(Dollars in millions, except per share data)

2024 % of Revenues 2023 % of Revenues Increase / Decrease $%
Revenues $9,610 100.0 $9,698 100.0 $(88) (0.9)
Cost of revenues(a) 6,350 66.1 6,374 65.7 (24) (0.4)
Selling, general and administrative expenses(a) 1,546 16.1 1,665 17.2 (119) (7.1)
Restructuring charges 52 0.5 117 1.2 (65) (55.6)
Depreciation and amortization expense 259 2.7 263 2.7 (4) (1.5)
Income from operations 1,403 14.6 1,279 13.2 124 9.7
Other income (expense), net 47 46 1 2.2
Income before provision for income taxes 1,450 15.1 1,325 13.7 125 9.4
Provision for income taxes (344) (282) (62) 22.0
Income (loss) from equity method investments 6 — 6 N/A
Net income $1,112 11.6 $1,043 10.8 $69 6.6
Diluted EPS $2.23 $2.05 $0.18 8.8
Other Financial Information6
Adjusted Income From Operations and Adjusted Operating Margin $1,455 15.1 $1,396 14.4 $59 4.2
Adjusted Diluted EPS $2.30 $2.21 $0.09 4.1

(a) Exclusive of depreciation and amortization expense.

N/A Not applicable

Revenues

During the six months ended June 30, 2024, revenues decreased by $88 million as compared to the six months ended June 30, 2023, a decrease of 0.9% on both a reported and a constant currency basis6. Our recently completed acquisitions contributed 70 basis points to revenue growth.

6 Adjusted Income from Operations, Adjusted Operating Margin, Adjusted Diluted EPS and constant currency revenue growth are not measures of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures.

Revenues - Reportable Business Segments and Geographic Markets

Revenues of $9,610 million across our business segments and geographies were as follows for the six months ended June 30, 2024:

(Dollars in millions)

YTD 2024 as compared to YTD 2023 Increase / (Decrease) $% CC %7
Financial Services $(107) (3.6) (3.7)
Health Sciences 4 0.1 0.2
Products and Resources (36) (1.6) (1.6)
CMT 51 3.2 3.1
Total revenues $(88) (0.9) (0.9)

(Dollars in millions)

YTD 2024 as compared to YTD 2023 Increase / (Decrease) $% CC %7
North America $7 0.1 0.1
United Kingdom (51) (5.4) (7.1)
Continental Europe (2) (0.2) (0.6)
Europe - Total (53) (2.8) (3.8)
Rest of World (42) (6.4) (3.9)
Total revenues $(88) (0.9) (0.9)

Change in revenues was driven by the following factors:7

  • Reduced demand for discretionary work negatively impacted revenues across all segments. Clients in our Financial Services and Products and Resources segments were particularly affected;
  • Recently completed acquisitions contributed 70 basis points of growth to the overall change in revenues, including 190 basis points of growth to our Communications, Media and Technology segment (primarily in North America and Continental Europe) and 70 basis points of growth to our Products and Resources segment (primarily in North America);
  • The resale of third-party products, primarily in the Health Sciences and Financial Services segments in North America, in connection with our integrated offerings strategy, contributed 110 basis points of growth to the overall change in revenue;
  • Health Sciences revenues were positively impacted by pharmaceutical clients in our Europe region, which was offset by the negative impact of the renegotiation of a large contract with a payer client in 2023 in our North America region, which reduced the scope of services but improved the profitability of the contract;
  • North America revenues in the Communications, Media and Technology and Health Sciences segments were positively impacted by the ramp up of several recently won large deals;
  • Revenue decline in our United Kingdom region was primarily driven by weakness in the Financial Services and Communications, Media and Technology segments; and
  • Revenue decline in our Rest of World region was primarily driven by weakness in the Financial Services and Products and Resources segments.

7 Constant currency revenue growth is not a measure of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures, as applicable.

Cost of Revenues (Exclusive of Depreciation and Amortization Expense)

ê $24M
é 0.4% as a % of revenues
¡ % of Revenues

Our cost of revenues consists primarily of salaries, incentive-based compensation, stock-based compensation expense, employee benefits, project-related immigration and travel for technical personnel, subcontracting and costs of third-party products and services relating to revenues. The increase, as a percentage of revenues, was due to higher compensation costs for delivery personnel and the impact of the resale of third-party products in connection with our integrated offerings strategy, partially offset by the beneficial impact of foreign currency exchange rate movements.

SG&A Expenses (Exclusive of Depreciation and Amortization Expense)

SG&A expenses consist primarily of salaries, incentive-based compensation, stock-based compensation expense, employee benefits, immigration, travel, marketing, communications, management, finance, administrative and occupancy costs. The decrease, as a percentage of revenues, was primarily driven by the net savings generated from our NextGen program.

ê $119M
ê 1.1% as a % of revenues
¡ % of Revenues

Restructuring Charges

Restructuring charges consist of costs related to the NextGen program. Restructuring charges were $52 million, or 0.5% as a percentage of revenue, for the six months ended June 30, 2024, as compared to $117 million, or 1.2% as a percentage of revenue, for the six months ended June 30, 2023. For further detail on our restructuring charges see Note 4 to our unaudited consolidated financial statements.

Depreciation and Amortization Expense

Depreciation and amortization expense decreased by 1.5%, and remained flat as a percentage of revenues, during the six months ended June 30, 2024 as compared to the 2023 period.

Operating Margin and Adjusted Operating Margin8- Overall

The increase in our 2024 GAAP operating margin and Adjusted Operating Margin8 was primarily driven by net savings generated from our NextGen program and the beneficial impact of foreign currency exchange rate movements, partially offset by increased compensation costs and the impact of the resale of third-party products in connection with our integrated offerings strategy. In addition, our 2023 and 2024 GAAP operating margins were negatively impacted by the NextGen charges, as discussed in Note 4 to our unaudited consolidated financial statements, which were excluded from our Adjusted Operating Margin.

Net of the impact of applicable designated cash flow hedges, the depreciation of the Indian rupee positively impacted our operating margin for the six months ended June 30, 2024 by 46 basis points as compared to the six months ended June 30, 2023. Excluding the impact of such hedges, the depreciation of the Indian rupee against the U.S. dollar positively impacted our operating margin by 24 basis points for the six months ended June 30, 2024. The settlement of our cash flow hedges had a positive impact of 4 basis points on our operating margin during the six months ended June 30, 2024, compared to a negative impact of 18 basis points during the 2023 period.

8 Adjusted Income from Operations and Adjusted Operating Margin are not measures of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and reconciliations to the most directly comparable GAAP financial measures, as applicable.

Segment Operating Profit

Segment operating profit and operating margin percentage were as follows:

Segment operating profit% Segment operating margin

In 2024, segment operating margins across all our segments were positively impacted by savings generated from our NextGen program and the beneficial impact of foreign currency exchange rate movements, partially offset by increased compensation costs. Segment operating profit in the Health Sciences and Communications, Media and Technology segments was negatively impacted by resales of third-party products in connection with our integrated offerings strategy and higher costs typical to the initial phases of several recently won large deals in these segments.

Total segment operating profit and margin were as follows for the six months ended June 30:

(Dollars in millions)

2024 % of Revenues 2023 % of Revenues Increase/(Decrease)
Total segment operating profit $1,943 20.2 $2,018 20.8 $(75)
Less: unallocated costs 540 5.6 739 7.6 (199)
Income from operations $1,403 14.6 $1,279 13.2 $124

Unallocated costs decreased for the six months ended June 30, 2024 as compared to the six months ended June 30, 2023, driven by lower corporate expenses as well as lower NextGen charges of $52 million for the six months ended June 30, 2024 as compared to $117 million for the six months ended June 30, 2023 (see Note 4 to our unaudited consolidated financial statements).

Other Income (Expense), Net

The following table sets forth total other income (expense), net for the six months ended June 30:

(in millions)

2024 2023 Increase/ Decrease
Foreign currency exchange (losses) gains $(21) $27 $(48)
Gains (losses) on foreign exchange forward contracts not designated as hedging instruments 28 (24) 52
Foreign currency exchange gains (losses), net 7 3 4
Interest income 60 60 —
Interest expense (21) (19) (2)
Other, net 1 2 (1)
Total other income (expense), net $47 $46 $1

The foreign currency exchange losses were attributed to the remeasurement of net monetary assets and liabilities denominated in currencies other than the functional currencies of our subsidiaries. The gains and losses on foreign exchange forward contracts not designated as hedging instruments related to the realized and unrealized gains and losses on contracts entered into to offset our foreign currency exposures. Interest income for the six months ended June 30, 2024 remained flat as compared to the same period in 2023. While our invested balances decreased during the six months ended June 30, 2024 due to the required payment related to the ITD dispute in January 2024 (see Note 8 to our unaudited consolidated financial statements), we benefited from higher interest rates compared to the six months ended June 30, 2023.

Provision for Income Taxes

é $62M
¡ Effective Income Tax Rate é 2.4%

The effective income tax rate in both periods reflects the benefits of discrete items related to U.S. state income taxes. The effective income tax rate in 2023 additionally benefited from the effective settlement of the IRS examination for tax years 2017 and 2018.

In December 2021, the OECD adopted model rules for a global framework to impose a 15% global minimum tax referred to as Pillar Two with an effective date of January 1, 2024. Although management continues to monitor additional guidance from the OECD and countries’ implementation of Pillar Two, based on current guidance, there was no material impact for the six months ended June 30, 2024 and we believe that our net income, cash flows, or financial condition will not be materially impacted in the future by Pillar Two.

Net Income

The increase in net income was driven by an increase in income from operations, partially offset by a higher effective tax rate.

é $69M
¡ é 0.8% of Revenues

Non-GAAP Financial Measures

See “Three Months Ended June 30, 2024 Compared to Three Months Ended June 30, 2023 – Non-GAAP Financial Measures” above for additional information about our use of non-GAAP financial measures.

The following table presents a reconciliation of each non-GAAP financial measure to the most comparable GAAP measure for the six months ended June 30:

(Dollars in millions, except per share amounts)

2024 % of Revenues 2023 % of Revenues
GAAP income from operations and operating margin $1,403 14.6 $1,279 13.2
NextGen charges (1) 52 0.5 117 1.2
Adjusted Income from Operations and Adjusted Operating Margin $1,455 15.1 $1,396 14.4
GAAP diluted EPS $2.23 $2.05
Effect of NextGen charges, pre-tax 0.10 0.23
Non-operating foreign currency exchange (gains) losses, pre-tax (2) (0.01) (0.01)
Tax effect of above adjustments (3) (0.02) (0.06)
Adjusted Diluted EPS $2.30 $2.21

(1) Consists of employee separation, facility exit and other costs incurred in connection with the NextGen program. See Note 4 to our unaudited consolidated financial statements for additional information.

(2) Non-operating foreign currency exchange gains and losses, inclusive of gains and losses on related foreign exchange forward contracts not designated as hedging instruments for accounting purposes, are reported in "Foreign currency exchange gains (losses), net" in our unaudited consolidated statements of operations.

(3) Presented below are the tax impacts of each of our non-GAAP adjustments to pre-tax income:

(in millions)

Non-GAAP income tax benefit (expense) related to: Six Months Ended June 30, 2024 2023
NextGen charges $13 $31
Foreign currency exchange gains and losses — 5

Cognizant Technology Solutions 38 June 30, 2024 Form 10-Q

The effective tax rate related to non-operating foreign currency exchange gains and losses varies depending on the jurisdictions in which such income and expenses are generated and the statutory rates applicable in those jurisdictions. As such, the income tax effect of non-operating foreign currency exchange gains and losses shown in the above table may not appear proportionate to the net pre-tax foreign currency exchange gains and losses reported in our unaudited consolidated statements of operations.

Liquidity and Capital Resources

Our cash generated from operations has historically been the primary source of liquidity to fund operations and investments to grow our business. As of June 30, 2024, we had cash, cash equivalents and short-term investments of $2,205 million and available capacity under our credit facility of approximately $1.9 billion.

The following table provides a summary of cash flows for the six months ended June 30:

(in millions)

Net cash provided by (used in): 2024 2023 Increase / Decrease
Operating activities $357 $765 $(408)
Investing activities (317) (300) (17)
Financing activities (525) (704) 179

Operating activities

The decrease in cash provided by operating activities for the six months ended June 30, 2024, as compared to the six months ended June 30, 2023, was primarily driven by the $360 million payment made in relation to our dispute with the ITD in January 2024 (see Note 8 to our unaudited consolidated financial statements) and lower collections of our trade accounts receivable, partially offset by lower other income tax payments.

We monitor turnover, aging and the collection of accounts receivable by client. Our DSO calculation includes receivables, net of allowance for doubtful accounts, and contract assets, reduced by the uncollected portion of deferred revenue. Our DSO was 80 days as of June 30, 2024, an increase of 3 days from 77 days as of December 31, 2023. Our DSO was 75 days as of June 30, 2023, an increase of 1 day from 74 days as of December 31, 2022.

Investing activities

The increase in cash used in investing activities for the six months ended June 30, 2024, as compared to the six months ended June 30, 2023, was primarily driven by lower net maturities of investments in 2024 as compared to 2023.

Financing activities

The decrease in cash used in financing activities for the six months ended June 30, 2024, as compared to the six months ended June 30, 2023, was primarily driven by lower repurchases of common stock, partially offset by higher term loan repayments in 2024.

We have a Credit Agreement providing for a $650 million Term Loan and a $1,850 million unsecured revolving credit facility, which are each due to mature in October 2027. We are required under the Credit Agreement to make scheduled quarterly principal payments on the Term Loan. We believe that we currently meet all conditions set forth in the Credit Agreement to borrow thereunder, and we are not aware of any conditions that would prevent us from borrowing part or all of the remaining available capacity under the revolving credit facility as of June 30, 2024 and through the date of this filing. As of June 30, 2024, we had no outstanding balance on the revolving credit facility. See Note 7 to our unaudited consolidated financial statements.

On June 10, 2024 we announced the signing of a definitive agreement to acquire Belcan for a preliminary purchase price of approximately $1.3 billion in cash and stock (1,470,589 shares of Class A Common Stock). Cash consideration is expected to be funded through a mix of cash on hand and debt. The transaction is anticipated to close in the quarter ending September 30, 2024, subject to the receipt of required regulatory approvals and other closing conditions.

Capital Allocation

Acquisitions

Share Repurchases

Dividend payments

We review our capital allocation on an ongoing basis, considering our financial performance and liquidity position, investments required to execute our strategic plans and initiatives, acquisition opportunities, the economic outlook, regulatory changes and other relevant factors. As these factors may change over time, the actual amounts expended on stock repurchase activity, dividends, and acquisitions, if any, during any particular period cannot be predicted and may fluctuate from time to time.

Other Liquidity and Capital Resources Information

We seek to ensure that our worldwide cash is available in the locations in which it is needed. As part of our ongoing liquidity assessments, we regularly monitor the mix of our domestic and international cash flows and cash balances. We evaluate on an ongoing basis what portion of the non-U.S. cash, cash equivalents and short-term investments is needed locally to execute our strategic plans and what amount is available for repatriation back to the United States.

We expect operating cash flows, cash and short-term investment balances, together with the available capacity under our revolving credit facilities, to be sufficient to meet our operating requirements, including purchase commitments, tax payments, including Tax Reform Act transition tax payments, and servicing our debt for the next twelve months. The ability to expand and grow our business in accordance with current plans, make acquisitions, meet long-term capital requirements beyond a twelve-month period and execute our capital return plan will depend on many factors, including the rate, if any, at which cash flow increases, our ability and willingness to pay for acquisitions with capital stock and the availability of public and private debt, including the ability to extend the maturity of or refinance our existing debt, and equity financing. We cannot be certain that additional financing, if required, will be available on terms and conditions acceptable to us, if at all.

Commitments and Contingencies

See Note 12 to our unaudited consolidated financial statements.

Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations is based on our unaudited consolidated financial statements that have been prepared in accordance with GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the amounts reported for assets and liabilities, including the recoverability of tangible and intangible assets, disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reported period. On an ongoing basis, we evaluate our estimates. The most significant estimates relate to the recognition of revenue and profits, including the application of the cost-to-cost method of measuring progress to completion for certain fixed-price contracts, income taxes, business combinations and valuation of goodwill and other long-lived assets. We base our estimates on historical experience, current trends and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual amounts may differ from the estimates used in the preparation of the accompanying unaudited consolidated financial statements. For a discussion of our critical accounting estimates, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2023. Our significant accounting policies are described in Note 1 to the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023.

Recently Adopted and New Accounting Pronouncements

There have been no changes in the information provided regarding recently adopted and new accounting pronouncements in our Annual Report on Form 10-K for the year ended December 31, 2023.

Market risk

As filed, 323 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in our quantitative and qualitative disclosures about market risk from those disclosed in Part II, Item 7A, Quantitative and Qualitative Disclosures about Market Risk, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on February 14, 2024.

Controls and procedures

As filed, 905 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our chief executive officer and our chief financial officer, evaluated the design and operating effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2024. Based on this evaluation, our chief executive officer and our chief financial officer concluded that, as of June 30, 2024, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

No changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 229 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC on February 14, 2024.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-04-01 to 2024-06-30$4.85bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2024-01-01 to 2024-06-30$9.61bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Selling, general and administrative3 months2024-04-01 to 2024-06-30$781.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2024-01-01 to 2024-06-30$1.55bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2024-04-01 to 2024-06-30$708.0mus-gaap:OperatingIncomeLoss
Operating income6 months2024-01-01 to 2024-06-30$1.40bnus-gaap:OperatingIncomeLoss
Interest expense3 months2024-04-01 to 2024-06-30$10.0mus-gaap:InterestExpense
Interest expense6 months2024-01-01 to 2024-06-30$21.0mus-gaap:InterestExpense
Income tax3 months2024-04-01 to 2024-06-30$165.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2024-01-01 to 2024-06-30$344.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-04-01 to 2024-06-30$566.0mus-gaap:NetIncomeLoss
Net income6 months2024-01-01 to 2024-06-30$1.11bnus-gaap:NetIncomeLoss
Diluted EPS3 months2024-04-01 to 2024-06-30$1.14us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2024-01-01 to 2024-06-30$2.23us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-04-01 to 2024-06-30$1.14us-gaap:EarningsPerShareBasic
Basic EPS6 months2024-01-01 to 2024-06-30$2.24us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-04-01 to 2024-06-30498,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2024-01-01 to 2024-06-30498,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2024-01-01 to 2024-06-30$357.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2024-01-01 to 2024-06-30$158.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2024-01-01 to 2024-06-30$301.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2024-01-01 to 2024-06-30$209.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2024-06-30$2.19bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-06-30$7.25bnus-gaap:AssetsCurrent
Total assetsAt period end2024-06-30$18.58bnus-gaap:Assets
Current liabilitiesAt period end2024-06-30$2.95bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-06-30$4.68bnus-gaap:Liabilities
Long-term debtAt period end2024-06-30$590.0mus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2024-06-30$33.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2024-06-30$13.90bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001058290-24-000242. Last ingested by Listed: Nov 11, 2026, 01:30 ET. Listed shows no prices and gives no investment advice.